Last week, our clinical engagement associates attended CHC at Boston’s Seaport World Trade Center. From Rx.Health, our team presented on successful impact of our Digital Navigation Program across multiple sites. The comparative study found the Digital Navigation Program (DNP) for colonoscopy is well adopted by patients, can reduce the rate of aborted procedures, and can result in higher patient satisfaction as well as a higher quality of bowel preparation.
Around 1 in 5 patients suffers from inadequate or poor bowel prep in advance of a colonoscopy. Studies have shown that this leads to a decrease in adenoma detection rate, reduced efficiency, increased time scoping in the endoscopy suite, as well as an overall increase in the cost of care from 13% to 20%. The aim of the comparative study presented at CHC was to assess the reproducibility of outcomes seen at Arizona Center for Digestive Health at additional sites that have implemented digital navigation for endoscopic procedures as part of the AGA network, including Yale New Haven Hospital (YNHH) and three Mount Sinai Hospital locations.
Rx.Health’s poster, featured over a two-day poster session, highlighted positive results using the DNP including patients who received the program were significantly more likely to have good or excellent bowel preparation quality than patients in usual care (n=81, 87.10% vs. 64.79%; p<0.05). In addition to an average 93.0% NPS patient satisfaction score, the poster emphasized the reduction in aborted procedures by half (1.07% vs 2.2%) across sites and a 34.5% improvement in overall bowel preparation.
Rx.Health is defining the delivery of digital medicine. Founded as a spinoff from the Mount Sinai Health System, a seven-hospital health system in New York City and a driving force in the rapid technological innovations in healthcare, Rx.Health is dedicated to facilitating the digital revolution in health. Rx.Health’s flagship product, RxUniverse, is the first enterprise-based Digital Medicine delivery system that enables physicians to prescribe evidence-based mobile health applications, wearables and therapeutics to patients at the point of care.